Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study to Assess Safety and Efficacy of Imiquimod 5% Cream Applied 3 Days Per Week in 1 or 2 Cycles for Treatment of Actinic Keratoses on the Head

NCT00175643 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00175643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study to Assess Safety and Efficacy of Imiquimod 5% Cream Applied 3 Days Per Week in 1 or 2 Cycles for Treatment of Actinic Keratoses on the Head
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
November 30, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses